Remote patient management (RPM) programs are one of the most crucial innovation in the peritoneal dialysis field, which has been developed in the last decade. RPM programs are associated with favorable clinical outcomes by increasing the adherence of the patients to peritoneal dialysis prescription. The literature supports that RPM is associated with increased blood pressure control and technique survival and decreased hospitalization rate, length of hospital stay, and health cost. The RPM program also facilitates patient follow-up in the COVID-19 pandemic, increases treatment adherence, and leads to better clinical outcomes. However, published data remains scarce and mainly consists of observational or retrospective studies with a relatively low number of patients. Therefore, randomized controlled trial results will be more informative to demonstrate the effect of RPM programs on clinical outcomes.